JP2002503245A5 - - Google Patents

Download PDF

Info

Publication number
JP2002503245A5
JP2002503245A5 JP1999501908A JP50190899A JP2002503245A5 JP 2002503245 A5 JP2002503245 A5 JP 2002503245A5 JP 1999501908 A JP1999501908 A JP 1999501908A JP 50190899 A JP50190899 A JP 50190899A JP 2002503245 A5 JP2002503245 A5 JP 2002503245A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1999501908A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002503245A (ja
JP4380803B2 (ja
Filing date
Publication date
Priority claimed from GBGB9712270.9A external-priority patent/GB9712270D0/en
Priority claimed from GBGB9724678.9A external-priority patent/GB9724678D0/en
Application filed filed Critical
Priority claimed from PCT/GB1998/001711 external-priority patent/WO1998056788A1/en
Publication of JP2002503245A publication Critical patent/JP2002503245A/ja
Publication of JP2002503245A5 publication Critical patent/JP2002503245A5/ja
Application granted granted Critical
Publication of JP4380803B2 publication Critical patent/JP4380803B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP50190899A 1997-06-12 1998-06-12 イミダゾリル−環式アセタール Expired - Lifetime JP4380803B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GBGB9712270.9A GB9712270D0 (en) 1997-06-12 1997-06-12 Chemical compounds
US5218597P 1997-07-10 1997-07-10
US60/052,185 1997-07-10
GBGB9724678.9A GB9724678D0 (en) 1997-11-21 1997-11-21 Chemical compounds
US8549998P 1998-05-14 1998-05-14
US60/085,499 1998-05-14
US9724678.9 1998-05-14
US9712270.9 1998-05-14
PCT/GB1998/001711 WO1998056788A1 (en) 1997-06-12 1998-06-12 Imidazolyl-cyclic acetals

Publications (3)

Publication Number Publication Date
JP2002503245A JP2002503245A (ja) 2002-01-29
JP2002503245A5 true JP2002503245A5 (cg-RX-API-DMAC7.html) 2005-12-08
JP4380803B2 JP4380803B2 (ja) 2009-12-09

Family

ID=27451664

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50190899A Expired - Lifetime JP4380803B2 (ja) 1997-06-12 1998-06-12 イミダゾリル−環式アセタール

Country Status (25)

Country Link
US (2) US6602877B1 (cg-RX-API-DMAC7.html)
EP (1) EP0988301B1 (cg-RX-API-DMAC7.html)
JP (1) JP4380803B2 (cg-RX-API-DMAC7.html)
KR (1) KR100704059B1 (cg-RX-API-DMAC7.html)
CN (1) CN100443481C (cg-RX-API-DMAC7.html)
AT (1) ATE335735T1 (cg-RX-API-DMAC7.html)
AU (1) AU742293B2 (cg-RX-API-DMAC7.html)
BR (1) BR9810007B1 (cg-RX-API-DMAC7.html)
CA (1) CA2293436C (cg-RX-API-DMAC7.html)
CY (1) CY1105238T1 (cg-RX-API-DMAC7.html)
CZ (1) CZ9904452A3 (cg-RX-API-DMAC7.html)
DE (1) DE69835518T2 (cg-RX-API-DMAC7.html)
DK (1) DK0988301T3 (cg-RX-API-DMAC7.html)
ES (1) ES2270520T3 (cg-RX-API-DMAC7.html)
HU (1) HUP0003309A3 (cg-RX-API-DMAC7.html)
IL (2) IL133311A0 (cg-RX-API-DMAC7.html)
NO (1) NO326660B1 (cg-RX-API-DMAC7.html)
NZ (1) NZ501714A (cg-RX-API-DMAC7.html)
PL (1) PL199893B1 (cg-RX-API-DMAC7.html)
PT (1) PT988301E (cg-RX-API-DMAC7.html)
RU (1) RU2221795C2 (cg-RX-API-DMAC7.html)
SK (2) SK171099A3 (cg-RX-API-DMAC7.html)
TR (1) TR199903098T2 (cg-RX-API-DMAC7.html)
TW (1) TWI235751B (cg-RX-API-DMAC7.html)
WO (1) WO1998056788A1 (cg-RX-API-DMAC7.html)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9713726D0 (en) 1997-06-30 1997-09-03 Ciba Geigy Ag Organic compounds
US7301021B2 (en) 1997-07-02 2007-11-27 Smithkline Beecham Corporation Substituted imidazole compounds
US6858617B2 (en) 1998-05-26 2005-02-22 Smithkline Beecham Corporation Substituted imidazole compounds
ES2221426T3 (es) * 1998-08-20 2004-12-16 Smithkline Beecham Corporation Nuevos compuestos de triazol sustituidos.
ATE336484T1 (de) 1998-08-29 2006-09-15 Astrazeneca Ab Pyrimidine verbindungen
AU5438299A (en) 1998-08-29 2000-03-21 Astrazeneca Ab Pyrimidine compounds
US6548503B1 (en) 1998-11-04 2003-04-15 Smithkline Beecham Corporation Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
EP1140916B1 (en) 1998-12-16 2002-11-13 Aventis Pharma Limited Heteroaryl-cyclic acetals
GB9828511D0 (en) 1998-12-24 1999-02-17 Zeneca Ltd Chemical compounds
GB9905075D0 (en) 1999-03-06 1999-04-28 Zeneca Ltd Chemical compounds
GB9907658D0 (en) 1999-04-06 1999-05-26 Zeneca Ltd Chemical compounds
US6291457B1 (en) 1999-07-01 2001-09-18 Merck & Co., Inc. Compounds having cytokine inhibitory activity
GB9919778D0 (en) 1999-08-21 1999-10-27 Zeneca Ltd Chemical compounds
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
CA2395564A1 (en) 1999-11-22 2001-05-31 Smithkline Beecham Plc Novel compounds
US6759410B1 (en) * 1999-11-23 2004-07-06 Smithline Beecham Corporation 3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
DE60023025T2 (de) 1999-11-23 2006-07-13 Smithkline Beecham Corp. 3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p39-kinase-inhibitoren
ES2230171T3 (es) 1999-11-23 2005-05-01 Smithkline Beecham Corporation Compuestos 3,4-dihidro-(1h)quinazolin-2-ona como inhibidores de csbp/p38 quinasa.
JP2003514900A (ja) 1999-11-23 2003-04-22 スミスクライン・ビーチャム・コーポレイション CSBP/p38キナーゼ阻害剤としての3,4−ジヒドロ−(1H)−キナゾリン−2−オン化合物
GB0004888D0 (en) 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds
GB0004887D0 (en) 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds
GB0004890D0 (en) 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds
GB0004886D0 (en) 2000-03-01 2000-04-19 Astrazeneca Uk Ltd Chemical compounds
US7235551B2 (en) 2000-03-02 2007-06-26 Smithkline Beecham Corporation 1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
GB0007371D0 (en) 2000-03-28 2000-05-17 Astrazeneca Uk Ltd Chemical compounds
GB0016877D0 (en) 2000-07-11 2000-08-30 Astrazeneca Ab Chemical compounds
GB0021726D0 (en) 2000-09-05 2000-10-18 Astrazeneca Ab Chemical compounds
GB0100762D0 (en) * 2001-01-11 2001-02-21 Smithkline Beecham Plc Novel use
WO2002062792A1 (en) * 2001-02-02 2002-08-15 Takeda Chemical Industries, Ltd. Jnk inhibitor
GB0103926D0 (en) 2001-02-17 2001-04-04 Astrazeneca Ab Chemical compounds
GB0112348D0 (en) * 2001-05-19 2001-07-11 Smithkline Beecham Plc Compounds
GB0113041D0 (en) 2001-05-30 2001-07-18 Astrazeneca Ab Chemical compounds
TR201809678T4 (tr) 2001-06-26 2018-07-23 Amgen Fremont Inc Opgl ye karşi antikorlar.
JP2005504793A (ja) * 2001-09-05 2005-02-17 スミスクライン ビーチャム パブリック リミテッド カンパニー Rafキナーゼ阻害剤としてのヘテロサイクルカルボキサミド誘導体
GB0205693D0 (en) 2002-03-09 2002-04-24 Astrazeneca Ab Chemical compounds
WO2003076434A1 (en) 2002-03-09 2003-09-18 Astrazeneca Ab 4- imidazolyl substuited pyrimidine derivatives with cdk inhibitiory activity
GB0205690D0 (en) 2002-03-09 2002-04-24 Astrazeneca Ab Chemical compounds
GB0205688D0 (en) 2002-03-09 2002-04-24 Astrazeneca Ab Chemical compounds
AR039241A1 (es) 2002-04-04 2005-02-16 Biogen Inc Heteroarilos trisustituidos y metodos para su produccion y uso de los mismos
AU2003245989A1 (en) 2002-07-09 2004-01-23 Boehringer Ingelheim Pharma Gmbh And Co. Kg Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
UA80295C2 (en) 2002-09-06 2007-09-10 Biogen Inc Pyrazolopyridines and using the same
GB0311276D0 (en) 2003-05-16 2003-06-18 Astrazeneca Ab Chemical compounds
GB0311274D0 (en) 2003-05-16 2003-06-18 Astrazeneca Ab Chemical compounds
TWI317286B (en) 2003-12-31 2009-11-21 Targeting delivery system
TW200528101A (en) 2004-02-03 2005-09-01 Astrazeneca Ab Chemical compounds
US20060035893A1 (en) 2004-08-07 2006-02-16 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
PE20060777A1 (es) 2004-12-24 2006-10-06 Boehringer Ingelheim Int Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
AU2006296386A1 (en) 2005-09-30 2007-04-05 Astrazeneca Ab Imidazo [1,2-a] pyridine having anti-cell-proliferation activity
JP2009512724A (ja) * 2005-10-24 2009-03-26 エフ.ホフマン−ラ ロシュ アーゲー Favorskii転位による環状ケタール化ケトンの製造およびグルコキナーゼ活性化剤:70を製造するためのその使用
EP1992344A1 (en) 2007-05-18 2008-11-19 Institut Curie P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
PE20120325A1 (es) * 2009-05-19 2012-04-12 Dow Agrosciences Llc Aminopirimidinas sustituidas con arilo como agentes fungicidas
CN111356687B (zh) * 2019-03-27 2021-03-30 广州必贝特医药技术有限公司 含嘧啶的三取代咪唑类化合物及其应用
KR20220151635A (ko) 2020-03-11 2022-11-15 에보텍 인터내셔널 게엠베하 통합 스트레스 반응 경로의 조절제

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3707475A (en) 1970-11-16 1972-12-26 Pfizer Antiinflammatory imidazoles
US3940486A (en) 1971-05-10 1976-02-24 Ciba-Geigy Corporation Imidazole derivatives in the treatment of pain
US4175127A (en) 1978-09-27 1979-11-20 Smithkline Corporation Pyridyl substituted 2,3-dihydroimidazo[2,1-b]thiazoles
WO1983002613A1 (fr) 1981-07-20 1983-08-04 Sallmann, Alfred Composes oxazoiques a triple substitution
US4503065A (en) 1982-08-03 1985-03-05 E. I. Du Pont De Nemours And Company Antiinflammatory 4,5-diaryl 1-2-halo imidazoles
US4728656A (en) 1985-12-12 1988-03-01 Smithkline Beckman Corporation 2,2-alkyldiylbis(thio)bis(imidazoles) useful for inhibition of the 5-lipoxygenase pathway
US4686231A (en) 1985-12-12 1987-08-11 Smithkline Beckman Corporation Inhibition of 5-lipoxygenase products
EP0264883A3 (en) 1986-10-21 1990-04-04 Banyu Pharmaceutical Co., Ltd. Substituted pyridine derivatives
IL84492A0 (en) 1986-11-21 1988-04-29 Ciba Geigy Ag Unsaturated phosphonic acids and derivatives
US4837350A (en) 1986-12-15 1989-06-06 Ciba-Geigy Corporation Process for the preparation of benzoin sulfonates
US5109002A (en) 1989-09-08 1992-04-28 Du Pont Merck Pharmaceutical Company Antipsychotic 1-cycloalkylpiperidines
IL95760A0 (en) * 1989-09-27 1992-05-25 Rhone Poulenc Sante Imidazole derivatives,their preparation and pharmaceutical compositions containing the same
GB9020889D0 (en) * 1990-09-25 1990-11-07 May & Baker Ltd New compositions of matter
US5102848A (en) 1990-09-28 1992-04-07 Union Carbide Chemicals & Plastics Technology Corporation Catalyst composition for oxidation of ethylene to ethylene oxide
GB9106508D0 (en) * 1991-03-27 1991-05-15 Rhone Poulenc Rorer Ltd New compositions of matter
US5179117A (en) 1991-12-20 1993-01-12 Du Pont Merck Pharmaceutical Company Antihypercholesterolemic 2-substituted imidazoles
US5656644A (en) * 1994-07-20 1997-08-12 Smithkline Beecham Corporation Pyridyl imidazoles
IL104369A0 (en) 1992-01-13 1993-05-13 Smithkline Beecham Corp Novel compounds and compositions
JP3264492B2 (ja) * 1992-01-13 2002-03-11 スミスクライン・ビーチャム・コーポレイション ピリジル置換イミダゾール
US5364875A (en) 1992-05-11 1994-11-15 The Du Pont Merck Pharmaceutical Company Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis
GB9303993D0 (en) 1993-02-26 1993-04-14 Fujisawa Pharmaceutical Co New heterocyclic derivatives
US5670527A (en) 1993-07-16 1997-09-23 Smithkline Beecham Corporation Pyridyl imidazole compounds and compositions
US5593992A (en) 1993-07-16 1997-01-14 Smithkline Beecham Corporation Compounds
US5593991A (en) 1993-07-16 1997-01-14 Adams; Jerry L. Imidazole compounds, use and process of making
AU7629594A (en) 1993-07-21 1995-02-20 Smithkline Beecham Corporation Imidazoles for treating cytokine mediated disease
JPH0753546A (ja) 1993-08-09 1995-02-28 Kuraray Co Ltd ジアリール置換複素環化合物およびその医薬用途
EP1306377A3 (en) 1993-11-08 2003-05-07 Smithkline Beecham Corporation Pyridyl-oxazoles and their use as cytokines inhibitors
EP0653421B1 (en) 1993-11-12 1997-01-15 Ishihara Sangyo Kaisha Ltd. Process for preparing 2-cyanoimidazole compounds
EP0793653A1 (en) 1994-11-23 1997-09-10 Neurogen Corporation Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligands
CA2228050A1 (en) 1995-08-10 1997-02-20 Harold G. Selnick 2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use
JP3294616B2 (ja) 1995-08-10 2002-06-24 メルク エンド カンパニー インコーポレーテッド 2−置換アリールピロール、このような化合物を含む組成物及び使用方法
JPH09124640A (ja) 1995-08-25 1997-05-13 Nippon Soda Co Ltd ピリジルイミダゾール化合物、製法および農園芸用殺菌剤
IL123950A (en) 1995-10-06 2001-04-30 Merck & Co Inc Substituted imidazoles having anti-cancer and cytokine inhibitory activity and pharmaceutical compositions containing them
GB2306108A (en) 1995-10-13 1997-04-30 Merck & Co Inc Treatment of Raf-mediated cancers with imidazole derivatives
WO1997016442A1 (en) 1995-10-31 1997-05-09 Merck & Co., Inc. Substituted pyridyl pyrroles, compositions containing such compounds and methods of use
AU7529096A (en) 1995-10-31 1997-05-22 Merck & Co., Inc. Substituted aryl pyrroles, compositions containing such compounds and methods of use
AU7482396A (en) 1995-10-31 1997-05-22 Merck & Co., Inc. Substituted aryl pyrroles, compositions containing such compounds and methods of use
JP3912758B2 (ja) 1996-02-16 2007-05-09 富士フイルム株式会社 1,1−ジ置換−1H−ベンゾ〔e〕インドール化合物の製造方法及び4〜9位ヒドロキシ基置換の該化合物
WO1997035855A1 (en) 1996-03-25 1997-10-02 Smithkline Beecham Corporation Novel treatment for cns injuries
GB0515625D0 (en) 2005-07-29 2005-09-07 Univ Manchester Hydrogel particle

Similar Documents

Publication Publication Date Title
JP2000510751A5 (cg-RX-API-DMAC7.html)
JP2000509942A5 (cg-RX-API-DMAC7.html)
JP2000509635A5 (cg-RX-API-DMAC7.html)
JP2000509912A5 (cg-RX-API-DMAC7.html)
JP2000509637A5 (cg-RX-API-DMAC7.html)
JP2000507042A5 (cg-RX-API-DMAC7.html)
JP2001527476A5 (cg-RX-API-DMAC7.html)
JP2000509587A5 (cg-RX-API-DMAC7.html)
JP2000507369A5 (cg-RX-API-DMAC7.html)
JP2000507433A5 (cg-RX-API-DMAC7.html)
JP2001525044A5 (cg-RX-API-DMAC7.html)
JP2000508866A5 (cg-RX-API-DMAC7.html)
JP2000510793A5 (cg-RX-API-DMAC7.html)
JP2000508022A5 (cg-RX-API-DMAC7.html)
JP2000508841A5 (cg-RX-API-DMAC7.html)
JP2000508680A5 (cg-RX-API-DMAC7.html)
JP2000509755A5 (cg-RX-API-DMAC7.html)
JP2001527597A5 (cg-RX-API-DMAC7.html)
JP2000510247A5 (cg-RX-API-DMAC7.html)
JP2000510969A5 (cg-RX-API-DMAC7.html)
JP2000508102A5 (cg-RX-API-DMAC7.html)
JP2001522321A5 (cg-RX-API-DMAC7.html)
JP2000509520A5 (cg-RX-API-DMAC7.html)
JP2001508559A5 (cg-RX-API-DMAC7.html)
JP2001526694A5 (cg-RX-API-DMAC7.html)